Company Number: 12999153

Analysis Date: 2025-07-20 13:40 UTC

1. Credit Opinion: CONDITIONAL APPROVAL
   SFHYDER LTD shows very limited financial resources as of the latest year ending March 2024, with net assets of only £287 compared to £22,353 the previous year. The drastic reduction in net current assets and cash reserves signals a significant liquidity tightening, raising concerns about the company’s ability to meet short-term obligations reliably. However, no overdue filings or insolvency indicators exist, and the business operates in a stable sector (general medical practice). Approval is conditional on understanding the cause of the financial decline and securing assurances regarding cash flow and working capital management going forward.

2. Financial Strength:
   The balance sheet reveals a sharp decline in net assets from £22,353 (2023) to £287 (2024). Current assets dropped from £46,973 to £25,027, mainly due to a reduction in cash from £46,973 to £20,027. Current liabilities remained stable around £24,700. The net current assets margin is now minimal (£287), indicating a near break-even working capital position. The company has minimal share capital (£1) and negligible retained earnings (£187), reflecting minimal equity buffer. This financial weakening reduces cushion against operational or economic shocks.

3. Cash Flow Assessment:
   Cash on hand has halved in the latest year and is barely covering current liabilities. Debtors of £5,000 provide some short-term cash inflow potential. The current liabilities to current assets ratio is near 1:1, indicating tight liquidity. Working capital management appears strained, requiring close monitoring of receivables collection and payables control to avoid cash shortfalls. The business's ability to service debt or absorb unexpected expenses is limited under present conditions.

4. Monitoring Points:

• Track monthly cash flow and liquidity ratios to ensure sufficient operational funds.
• Monitor debtor aging and collection effectiveness.
• Watch for any increases in current liabilities or delayed payments to suppliers.
• Review management actions to rebuild equity or improve profitability.
• Confirm no adverse changes in director conduct or legal compliance.
• Assess potential impact of sector-specific risks in medical practice environment.